Key facts
- This page summarizes Iwicki Mark T.'s Form 4 filing for KALA BIO, Inc. (KALA).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 26 Jun 2025, 20:00.
Iwicki Mark T. - 24 Jun 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)
- Role
- Director
- Signature
- /s/ Mary Reumuth, Attorney-in-Fact
- Issuer symbol
- KALA
- Transactions as of
- 24 Jun 2025
- Net transactions value
- -$53,040
- Form type
- 4
- Filing time
- 26 Jun 2025, 20:00:11 UTC
- Previous filing
- 17 Jun 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Key filing fact
Iwicki Mark T. filed Form 4 for KALA BIO, Inc. (KALA) on 26 Jun 2025.
Change
- Previous filing in this sequence was filed on 17 Jun 2025.
- Current net transaction value: -$53,040.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001415537
Primary reporting owner
Iwicki Mark T
- Relationship
- Director
- Address
- C/O KALA BIO, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON
- Signature
- /s/ Mary Reumuth, Attorney-in-Fact
- Signature date
- 26 Jun 2025
Transactions Table
KALA
transaction
Common Stock
Sale
- Transaction value
- $53,040
- Shares
- -13,227
- Change %
- -4.9%
- Price
- $4.01
- Shares after
- 258,433
- Date
- 24 Jun 2025
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 9, 2020 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ("RSUs") granted on June 22, 2023. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.87 to $4.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F3 | Includes 103,540 unvested RSUs. |